Update from Dr. Alison Skrinar on the Ultragenyx trials, Orbit and Cosmic – OI Foundation
Ultragenyx Receives an Extended Approval for Evkeeza by the EC for 5 Years or Older Children with Homozygous Familial Hypercholesterolemia (HoFH)
PANTHERx® Rare Pharmacy Selected by Ultragenyx Pharmaceutical to Distribute DOJOLVI™ (triheptanoin), for Patients with Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) - PANTHERx Rare
Press releases—Ultragenyx Pharmaceutical Inc.
FOUNDATION FOR ANGELMAN SYNDROME THERAPEUTICS (FAST) ANNOUNCES SALE OF ITS SHARES IN GENETX TO ULTRAGENYX
Press releases—Ultragenyx Pharmaceutical Inc.
GeneTx and Ultragenyx Announce Investigational New Drug
Ultragenyx: Outstanding Q4 2018 Results (NASDAQ:RARE) | Seeking Alpha
Events & presentations—Ultragenyx Pharmaceutical Inc.
Ultragenyx (RARE) Acquires Rights of AAV Gene Therapy Candidate
Press releases—Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc. (RARE) Stock Price, Quote & News - Stock Analysis
Ultragenyx Overview | SignalHire Company Profile
Ultragenyx Pharmaceutical Inc.
Ultragenyx's Corporate Sustainability Journey—Ultragenyx
Events & presentations—Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Press Release
Investors & Media—Ultragenyx Pharmaceutical Inc.
Ultragenyx Announces Proposed Public Offering of Common Stock | RARE Stock News
DOJ Civil Division on X: "Pharmaceutical Company Ultragenyx Agrees to Pay $6 Million for Allegedly Paying Kickbacks to Induce Claims for Its Drug Crysvita https://t.co/Zx3qbY0FcH https://t.co/qhCWcKvyDM" / X
Ultragenyx Signs a License Agreement with Mereo for Setrusumab in Osteogenesis Imperfecta
Press releases—Ultragenyx Pharmaceutical Inc.
Events & presentations—Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical, Inc. Aktie News
Ultragenyx Pharmaceutical Q4 2022 Earnings Transcript
Ultragenyx and Solid Biosciences Announce Strategic Collaboration to Develop and Commercialize New Gene Therapies for Duchenne Muscular Dystrophy - CureDuchenne
Articles about Ultragenyx Pharmaceutical Inc.
GeneTx and Ultragenyx Announce Investigational New Drug
Ultragenyx Fights for Cures Amid Rising R&D Costs - NAM
